debrisoquin has been researched along with Neurotic Disorders in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertilsson, L | 1 |
| Dahl, ML | 1 |
| Sjöqvist, F | 1 |
| Aberg-Wistedt, A | 1 |
| Humble, M | 1 |
| Johansson, I | 1 |
| Lundqvist, E | 1 |
| Ingelman-Sundberg, M | 1 |
1 other study available for debrisoquin and Neurotic Disorders
| Article | Year |
|---|---|
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine.
Topics: Debrisoquin; Female; Humans; Hydroxylation; Metabolic Diseases; Neurotic Disorders; Polymorphism, Re | 1993 |